The Knight Diagnostic Laboratories include a molecular translational research lab and three genetics laboratories specializing in molecular genetics, cytogenetics, and FISH analyses.
Chromosome analysis and fluorescent in situ hybridization (FISH) testing have long been key components in the diagnosis and prognosis of hematologic malignancies, and recently, FISH has become an essential component in therapeutic decisions for solid tumor patients as well.
The Knight Cancer Institute at Oregon Health & Science University is a pioneer in the field of precision cancer medicine. The institute's director, Brian Druker, M.D., helped prove it was possible to shut down just the cells that enable cancer to grow. This breakthrough has made once-fatal forms of the disease manageable and transformed how cancer is treated. The OHSU Knight Cancer Institute is the only National Cancer Institute-designated Cancer Center between Sacramento and Seattle – an honor earned only by the nation's top cancer centers. It is headquarters for one of the National Cancer Institute's largest research collaboratives, SWOG, in addition to offering the latest treatments and technologies as well as hundreds of research studies and clinical trials.
Learn More